HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: Application of the haplotype method

Ana M. Valdes, Shannon McWeeney, Glenys Thomson

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Insulin-dependent diabetes mellitus (IDDM) HLA class II DRB1-DQA1-DQB1 data from four populations (Norwegian, Sardinian, Mexican American, and Taiwanese) have been analyzed to detect the amino acids involved in the disease process. The combination of sites DRB1 67 and 86; DQA1 47; and DQB1 9, 26, 57, and 70 predicts the IDDM component in these four populations, when the results and criteria of the haplotype method for amino acids, developed in the companion paper in this issue of the Journal, are used. The following sites, either individually, or in various combinations, previously have been suggested as IDDM components: DRB1 57, 70, 71, and 86; DQA1 52; and DQB1 13, 45, and 57 (DQB1 13 and 45 correlates 100% with DQB1 9 and 26). We propose that DQA1 47 is a better predictor of IDDM than is the previously suggested DQA1 52, and we add DRB1 67 and DQB1 70 to the HLA DR-DQ IDDM amino acids. We do not claim to have identified all HLA DR-DQ amino acids-or highly correlated sites-involved in IDDM. The frequencies and predisposing/protective effects of the haplotypes defined by these seven sites have been compared, and the effects on IDDM are consistent across the populations. The strongest susceptible effects came from haplotypes DRB1*0301/DQA1*0501/DQB1*0201 and DRB1*0401-5-7-8/DQA1*0301/DQB1*0302. The number of strong protective haplotypes observed was larger than the number of susceptible ones; some of the predisposing haplotypes were present in only one or two populations. Although the sites under consideration do not necessarily have a functional involvement in IDDM, they should be highly associated with such sites and should prove to be useful in risk assessment.

Original languageEnglish (US)
Pages (from-to)717-728
Number of pages12
JournalAmerican Journal of Human Genetics
Volume60
Issue number3
StatePublished - Mar 1997
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Haplotypes
Amino Acids
HLA-DQ Antigens
HLA-DR Antigens
Population

ASJC Scopus subject areas

  • Genetics

Cite this

HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus : Application of the haplotype method. / Valdes, Ana M.; McWeeney, Shannon; Thomson, Glenys.

In: American Journal of Human Genetics, Vol. 60, No. 3, 03.1997, p. 717-728.

Research output: Contribution to journalArticle

@article{6a7206d28669497aa0e5981bacafc45e,
title = "HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: Application of the haplotype method",
abstract = "Insulin-dependent diabetes mellitus (IDDM) HLA class II DRB1-DQA1-DQB1 data from four populations (Norwegian, Sardinian, Mexican American, and Taiwanese) have been analyzed to detect the amino acids involved in the disease process. The combination of sites DRB1 67 and 86; DQA1 47; and DQB1 9, 26, 57, and 70 predicts the IDDM component in these four populations, when the results and criteria of the haplotype method for amino acids, developed in the companion paper in this issue of the Journal, are used. The following sites, either individually, or in various combinations, previously have been suggested as IDDM components: DRB1 57, 70, 71, and 86; DQA1 52; and DQB1 13, 45, and 57 (DQB1 13 and 45 correlates 100{\%} with DQB1 9 and 26). We propose that DQA1 47 is a better predictor of IDDM than is the previously suggested DQA1 52, and we add DRB1 67 and DQB1 70 to the HLA DR-DQ IDDM amino acids. We do not claim to have identified all HLA DR-DQ amino acids-or highly correlated sites-involved in IDDM. The frequencies and predisposing/protective effects of the haplotypes defined by these seven sites have been compared, and the effects on IDDM are consistent across the populations. The strongest susceptible effects came from haplotypes DRB1*0301/DQA1*0501/DQB1*0201 and DRB1*0401-5-7-8/DQA1*0301/DQB1*0302. The number of strong protective haplotypes observed was larger than the number of susceptible ones; some of the predisposing haplotypes were present in only one or two populations. Although the sites under consideration do not necessarily have a functional involvement in IDDM, they should be highly associated with such sites and should prove to be useful in risk assessment.",
author = "Valdes, {Ana M.} and Shannon McWeeney and Glenys Thomson",
year = "1997",
month = "3",
language = "English (US)",
volume = "60",
pages = "717--728",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus

T2 - Application of the haplotype method

AU - Valdes, Ana M.

AU - McWeeney, Shannon

AU - Thomson, Glenys

PY - 1997/3

Y1 - 1997/3

N2 - Insulin-dependent diabetes mellitus (IDDM) HLA class II DRB1-DQA1-DQB1 data from four populations (Norwegian, Sardinian, Mexican American, and Taiwanese) have been analyzed to detect the amino acids involved in the disease process. The combination of sites DRB1 67 and 86; DQA1 47; and DQB1 9, 26, 57, and 70 predicts the IDDM component in these four populations, when the results and criteria of the haplotype method for amino acids, developed in the companion paper in this issue of the Journal, are used. The following sites, either individually, or in various combinations, previously have been suggested as IDDM components: DRB1 57, 70, 71, and 86; DQA1 52; and DQB1 13, 45, and 57 (DQB1 13 and 45 correlates 100% with DQB1 9 and 26). We propose that DQA1 47 is a better predictor of IDDM than is the previously suggested DQA1 52, and we add DRB1 67 and DQB1 70 to the HLA DR-DQ IDDM amino acids. We do not claim to have identified all HLA DR-DQ amino acids-or highly correlated sites-involved in IDDM. The frequencies and predisposing/protective effects of the haplotypes defined by these seven sites have been compared, and the effects on IDDM are consistent across the populations. The strongest susceptible effects came from haplotypes DRB1*0301/DQA1*0501/DQB1*0201 and DRB1*0401-5-7-8/DQA1*0301/DQB1*0302. The number of strong protective haplotypes observed was larger than the number of susceptible ones; some of the predisposing haplotypes were present in only one or two populations. Although the sites under consideration do not necessarily have a functional involvement in IDDM, they should be highly associated with such sites and should prove to be useful in risk assessment.

AB - Insulin-dependent diabetes mellitus (IDDM) HLA class II DRB1-DQA1-DQB1 data from four populations (Norwegian, Sardinian, Mexican American, and Taiwanese) have been analyzed to detect the amino acids involved in the disease process. The combination of sites DRB1 67 and 86; DQA1 47; and DQB1 9, 26, 57, and 70 predicts the IDDM component in these four populations, when the results and criteria of the haplotype method for amino acids, developed in the companion paper in this issue of the Journal, are used. The following sites, either individually, or in various combinations, previously have been suggested as IDDM components: DRB1 57, 70, 71, and 86; DQA1 52; and DQB1 13, 45, and 57 (DQB1 13 and 45 correlates 100% with DQB1 9 and 26). We propose that DQA1 47 is a better predictor of IDDM than is the previously suggested DQA1 52, and we add DRB1 67 and DQB1 70 to the HLA DR-DQ IDDM amino acids. We do not claim to have identified all HLA DR-DQ amino acids-or highly correlated sites-involved in IDDM. The frequencies and predisposing/protective effects of the haplotypes defined by these seven sites have been compared, and the effects on IDDM are consistent across the populations. The strongest susceptible effects came from haplotypes DRB1*0301/DQA1*0501/DQB1*0201 and DRB1*0401-5-7-8/DQA1*0301/DQB1*0302. The number of strong protective haplotypes observed was larger than the number of susceptible ones; some of the predisposing haplotypes were present in only one or two populations. Although the sites under consideration do not necessarily have a functional involvement in IDDM, they should be highly associated with such sites and should prove to be useful in risk assessment.

UR - http://www.scopus.com/inward/record.url?scp=0031035360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031035360&partnerID=8YFLogxK

M3 - Article

C2 - 9042932

AN - SCOPUS:0031035360

VL - 60

SP - 717

EP - 728

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 3

ER -